Cargando…

Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors

Detalles Bibliográficos
Autores principales: Choi, Yun Jung, Park, Gun Min, Rho, Jin Kyung, Kim, Sun Ye, So, Gwang Sup, Kim, Hyeong Ryul, Choi, Chang-Min, Lee, Jae Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417663/
https://www.ncbi.nlm.nih.gov/pubmed/30870512
http://dx.doi.org/10.1371/journal.pone.0213984
_version_ 1783403601378410496
author Choi, Yun Jung
Park, Gun Min
Rho, Jin Kyung
Kim, Sun Ye
So, Gwang Sup
Kim, Hyeong Ryul
Choi, Chang-Min
Lee, Jae Cheol
author_facet Choi, Yun Jung
Park, Gun Min
Rho, Jin Kyung
Kim, Sun Ye
So, Gwang Sup
Kim, Hyeong Ryul
Choi, Chang-Min
Lee, Jae Cheol
author_sort Choi, Yun Jung
collection PubMed
description
format Online
Article
Text
id pubmed-6417663
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64176632019-04-01 Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors Choi, Yun Jung Park, Gun Min Rho, Jin Kyung Kim, Sun Ye So, Gwang Sup Kim, Hyeong Ryul Choi, Chang-Min Lee, Jae Cheol PLoS One Correction Public Library of Science 2019-03-14 /pmc/articles/PMC6417663/ /pubmed/30870512 http://dx.doi.org/10.1371/journal.pone.0213984 Text en © 2019 Choi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Choi, Yun Jung
Park, Gun Min
Rho, Jin Kyung
Kim, Sun Ye
So, Gwang Sup
Kim, Hyeong Ryul
Choi, Chang-Min
Lee, Jae Cheol
Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title_full Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title_fullStr Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title_full_unstemmed Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title_short Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
title_sort correction: role of igf-binding protein 3 in the resistance of egfr mutant lung cancer cells to egfr-tyrosine kinase inhibitors
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417663/
https://www.ncbi.nlm.nih.gov/pubmed/30870512
http://dx.doi.org/10.1371/journal.pone.0213984
work_keys_str_mv AT choiyunjung correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT parkgunmin correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT rhojinkyung correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT kimsunye correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT sogwangsup correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT kimhyeongryul correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT choichangmin correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors
AT leejaecheol correctionroleofigfbindingprotein3intheresistanceofegfrmutantlungcancercellstoegfrtyrosinekinaseinhibitors